Recursion Pharmaceuticals
RXRX
$8.12
Share price
3.57%
Change (1 day)
63.38%
Change (1 year)
Categories
Recursion Pharmaceuticals (RXRX) - P/B ratio
P/B ratio as of April 2024 : 4.15
According to Recursion Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 4.15.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Recursion Pharmaceuticals - P/B ratio (from 2021 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.59 | 52.67% |
| 2022-12-31 | 3.01 | -43.58% |
| 2021-12-31 | 5.33 | |
| 2020-12-31 | N/A |